Stay updated on Anetumab Ravtansine Multi-indication Clinical Trial

Sign up to get notified when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anetumab Ravtansine Multi-indication Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    A new revision tag v3.5.4 was added, replacing v3.5.3, indicating a routine site update without changes to the study details or page content.
    Difference
    0.0%
    Check dated 2026-05-17T09:24:00.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s page version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site release rather than a change to the trial content.
    Difference
    0.0%
    Check dated 2026-04-25T18:42:52.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:28:20.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-28T01:41:17.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3. No user-facing content or study details appear to be affected.
    Difference
    0.0%
    Check dated 2026-03-06T17:52:08.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Minor site-wide footer and label edits include the addition of a revision note (Revision: v3.4.2) and the removal of Bayer-related links/labels such as 'Click here to find results for studies related to Bayer products', 'Bayer', and 'Helpful Links Provided by'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:48:29.000Z thumbnail image

Stay in the know with updates to Anetumab Ravtansine Multi-indication Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.